Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Neurology ; 102(4): e208019, 2024 Feb 27.
Article in English | MEDLINE | ID: mdl-38266213

ABSTRACT

BACKGROUND AND OBJECTIVES: Longitudinal outcomes in anti-NMDA receptor encephalitis (anti-NMDARe) are still not fully understood and may not be adequately captured with the modified Rankin Scale (mRS), often the sole reported outcome. We aim to characterize longitudinal outcomes in anti-NMDARe using multiple outcome measures. METHODS: This single-center, retrospective, observational study examined outcome measures (mRS and Clinical Assessment Scale in Autoimmune Encephalitis [CASE]) in adults with NMDA receptor-IgG in CSF at short- and long-term follow-ups using linear and logistic regression modeling. Patients with evaluations for cognitive impairment (Montreal Cognitive Assessment/Mini-Mental State Examination), depression (Patient Health Questionnaire-9), and anxiety (General Anxiety Disorder-7) >6 months from symptom onset were correlated with final CASE scores. RESULTS: Thirty-eight patients (76% female, median disease onset age = 28 years, range = 1-75 years) were included. The majority received first-line immunosuppressants (97%) at a median of 3.9 weeks (interquartile range [IQR] = 2.1-9.7) from symptom onset and 68% received second-line therapies. At baseline, median/mean mRS and CASE were 4 (IQR = 3-5) and 12.9 (SD = 7.2), respectively. At short-term follow-up (median = 10 weeks, IQR = 6-17), factors associated with higher CASE and mRS included dysautonomia, coma/lethargy, seizures/status epilepticus, and intensive care unit admission (p < 0.05). At long-term follow-up (median = 70 weeks, IQR = 51-174), median/mean mRS and CASE were 2 (IQR = 1-3) and 4.4 (SD = 4.2), respectively. Only weakness at symptom onset predicted higher mRS scores (odds ratio = 5.6, 95% confidence interval 1.02-30.9, p = 0.047). Despite both mRS and CASE improving from baseline (p < 0.001), only 9 patients (31%) returned to their premorbid function. Among patients with cognitive and mood evaluations >6 months from onset, moderate-severe cognitive impairment (42%), depression (28%), and anxiety (30%) were frequent. Cognitive and depression measures were associated with final CASE subscores (including memory, language, weakness, and psychiatric). DISCUSSION: Multiple clinical factors influenced short-term outcomes, but only onset weakness influenced long-term mRS, highlighting that mRS is predominantly affected by global motor function. Although mRS and CASE improved over time for most patients, these outcome measures did not capture the full extent of long-term functional impairment in terms of mood, cognition, and the ability to return to premorbid function. This emphasizes the need for increased utilization of more nuanced cognitive and mood outcome measures.


Subject(s)
Anti-N-Methyl-D-Aspartate Receptor Encephalitis , Cognitive Dysfunction , Encephalitis , Hashimoto Disease , Adult , Humans , Female , Infant , Child, Preschool , Child , Adolescent , Young Adult , Middle Aged , Aged , Male , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/complications , Anti-N-Methyl-D-Aspartate Receptor Encephalitis/diagnosis , Anxiety Disorders , Cognitive Dysfunction/etiology
3.
Infect Control Hosp Epidemiol ; 43(1): 105-107, 2022 Jan.
Article in English | MEDLINE | ID: mdl-33427146

ABSTRACT

The vacuum-exhausted isolation locker (VEIL) provides a safety barrier during the care of COVID-19 patients. The VEIL is a 175-L enclosure with exhaust ports to continuously extract air through viral particle filters connected to hospital suction. Our experiments show that the VEIL contains and exhausts exhaled aerosols and droplets.


Subject(s)
COVID-19 , Aerosols , Humans , Inpatients , Pandemics , SARS-CoV-2 , Vacuum
4.
Neurology ; 97(20): 942-957, 2021 11 16.
Article in English | MEDLINE | ID: mdl-34782410

ABSTRACT

BACKGROUND AND OBJECTIVES: To review the current evidence on the options available for initiating dopaminergic treatment of motor symptoms in early-stage Parkinson disease and provide recommendations to clinicians. METHODS: A multidisciplinary panel developed practice recommendations, integrating findings from a systematic review and following an Institute of Medicine-compliant process to ensure transparency and patient engagement. Recommendations were supported by structured rationales, integrating evidence from the systematic review, related evidence, principles of care, and inferences from evidence. RESULTS: Initial treatment with levodopa provides superior motor benefit compared to treatment with dopamine agonists, whereas levodopa is more likely than dopamine agonists to cause dyskinesia. The comparison of different formulations of dopamine agonists yielded little evidence that any one formulation or method of administration is superior. Long-acting forms of levodopa and levodopa with entacapone do not appear to differ in efficacy from immediate-release levodopa for motor symptoms in early disease. There is a higher risk of impulse control disorders associated with the use of dopamine agonists than levodopa. Recommendations on initial therapy for motor symptoms are provided to assist the clinician and patient in choosing between treatment options and to guide counseling, prescribing, and monitoring of efficacy and safety.


Subject(s)
Dopamine Agents , Motor Activity , Parkinson Disease , Dopamine Agents/adverse effects , Dopamine Agents/therapeutic use , Dopamine Agonists/adverse effects , Dopamine Agonists/therapeutic use , Dyskinesia, Drug-Induced , Humans , Levodopa/adverse effects , Levodopa/therapeutic use , Motor Activity/physiology , Parkinson Disease/drug therapy , Parkinson Disease/physiopathology , Practice Guidelines as Topic
5.
Clin Neuropsychol ; 35(3): 572-596, 2021 04.
Article in English | MEDLINE | ID: mdl-31790343

ABSTRACT

OBJECTIVE: While the Neuropsychological Assessment Battery, Screening Module (S-NAB) is a commonly used cognitive screening measure, no composite embedded performance validity test (PVT) formula has yet been described within it. This study sought to empirically derive PVT formulas within the S-NAB using an analog simulation paradigm. METHOD: Seventy-two university students (M age = 18.92) were randomly assigned to either an Asymptomatic (AS) or simulated mild traumatic brain injury (S-mTBI) group and were administered a neuropsychological test battery that included the S-NAB and standalone and embedded PVTs. The AS group was instructed to perform optimally, and the S-mTBI group received symptom and test coaching to help simulate mTBI-related impairment. Both groups received warnings regarding the presence of PVTs throughout the test battery. RESULTS: Groups showed significant differences (all ps < .001) on all S-NAB domain scores and PVTs. In the S-NAB, the Attention (S-ATT) and Executive Function (S-EXE) domains showed the largest effect sizes (Cohen's ds = 2.02 and 1.79, respectively). Seven raw scores from S-ATT and S-EXE subtests were entered as predictor variables in a direct logistic regression (LR). The model accurately classified 90.3% of cases. Two PVT formulas were described: (1) an exponentiated equation from LR results and (2) an arithmetic formula using four individually meaningful variables. Both formulas demonstrated outstanding discriminability between groups (AUCs = .96-.97) and yielded good classification statistics compared to other PVTs. CONCLUSIONS: This study is the first to describe composite, embedded PVT formulas within the S-NAB. Implications, limitations, and appropriate future directions of inquiry are discussed.


Subject(s)
Neuropsychological Tests , Brain Concussion , Executive Function , Humans , Mass Screening , Psychometrics , Reproducibility of Results
6.
BMJ Evid Based Med ; 25(5): 168-171, 2020 10.
Article in English | MEDLINE | ID: mdl-32430395

ABSTRACT

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3-4.5 hours after stroke onset. However, baseline imbalances in history of prior stroke and stroke severity score may confound this apparent finding of efficacy. We reanalysed the ECASS III trial data adjusting for baseline imbalances to determine the robustness or sensitivity of the efficacy estimates. DESIGN: Reanalysis of randomised placebo-controlled trial. We obtained access to the ECASS III trial data and replicated the previously reported analyses to confirm our understanding of the data. We adjusted for baseline imbalances using multivariable analyses and stratified analyses and performed sensitivity analysis for missing data. SETTING: Emergency care. PARTICIPANTS: 821 adults with acute ischaemic stroke who could be treated 3-4.5 hours after symptom onset. INTERVENTIONS: Intravenous alteplase (0.9 mg/kg of body weight) or placebo. MAIN OUTCOME MEASURES: The original primary efficacy outcome was modified Rankin Scale (mRS) score 0 or 1 (ie, being alive without any disability) and the original secondary efficacy outcome was a global outcome based on a composite of functional end points, both at 90 days. Adjusted analyses were only reported for the primary efficacy outcome and the original study protocol did not specify methods for adjusted analyses. Our adjusted reanalysis included these outcomes, symptom-free status (mRS 0), dependence-free status (mRS 0-2), mortality (mRS 6) and change across the mRS 0-6 spectrum at 90 days; and mortality and symptomatic intracranial haemorrhage at 7 days. RESULTS: We replicated previously reported unadjusted analyses but discovered they were based on a modified interpretation of the National Institutes of Health Stroke Scale (NIHSS) score. The secondary efficacy outcome was no longer significant using the original NIHSS score. Previously reported adjusted analyses could only be replicated with significant effects for the primary efficacy outcome by using statistical approaches not reported in the trial protocol or statistical analysis plan. In analyses adjusting for baseline imbalances, all efficacy outcomes were not significant, but increases in symptomatic intracranial haemorrhage remained significant. CONCLUSIONS: Reanalysis of the ECASS III trial data with multiple approaches adjusting for baseline imbalances does not support any significant benefits and continues to support harms for the use of alteplase 3-4.5 hours after stroke onset. Clinicians, patients and policymakers should reconsider interpretations and decisions regarding management of acute ischaemic stroke that were based on ECASS III results. TRIAL REGISTRATION NUMBER: NCT00153036.


Subject(s)
Data Interpretation, Statistical , Fibrinolytic Agents/administration & dosage , Ischemic Stroke/drug therapy , Randomized Controlled Trials as Topic/statistics & numerical data , Thrombolytic Therapy , Tissue Plasminogen Activator/administration & dosage , Administration, Intravenous , Adult , Emergency Service, Hospital , Humans , Randomized Controlled Trials as Topic/standards , Time-to-Treatment , Treatment Outcome
8.
Hosp Pediatr ; 10(1): 43-51, 2020 01.
Article in English | MEDLINE | ID: mdl-31811046

ABSTRACT

OBJECTIVES: The rate of pediatric 7-day unplanned readmissions is often seen as a measure of quality of care, with high rates indicative of the need for improvement of quality of care. In this study, we used machine learning on electronic health records to study predictors of pediatric 7-day readmissions. We ranked predictors by clinical significance, as determined by the magnitude of the least absolute shrinkage and selection operator regression coefficients. METHODS: Data consisting of 50 241 inpatient and observation encounters at a single tertiary pediatric hospital were retrieved; 50% of these patients' data were used for building a least absolute shrinkage and selection operator regression model, whereas the other half of the data were used for evaluating model performance. The categories of variables included were demographics, social determinants of health, severity of illness and acuity, resource use, diagnoses, medications, psychosocial factors, and other variables such as primary care no show. RESULTS: Previous hospitalizations and readmissions, medications, multiple comorbidities, longer current and previous lengths of stay, certain diagnoses, and previous emergency department use were the most significant predictors modifying a patient's risk of 7-day pediatric readmission. The model achieved an area under the curve of 0.778 (95% confidence interval 0.763-0.793). CONCLUSIONS: Predictors such as medications, previous and current health care resource use, history of readmissions, severity of illness and acuity, and certain psychosocial factors modified the risk of unplanned 7-day readmissions. These predictors are mostly unmodifiable, indicating that intervention plans on high-risk patients may be developed through discussions with patients and parents to identify underlying modifiable causal factors of readmissions.


Subject(s)
Patient Readmission , Pediatrics , Child , Hospitals, Pediatric , Humans , Length of Stay , Models, Statistical , Retrospective Studies , Risk Factors , Tertiary Care Centers
10.
MethodsX ; 6: 827-836, 2019.
Article in English | MEDLINE | ID: mdl-31049299

ABSTRACT

Quantitative landslide risk analysis is a key step in creating appropriate land use policies. However, regional scale landslide hazard and risk studies are traditionally based on a single, infinite-slope style of failure, belying the differing consequences of a diverse range of failure modes. In this paper we expand an existing multimodal coseismic landslide hazard model to create a method for multimodal, multi-trigger quantitative landslide risk analysis and apply it to the country of Lebanon. •Physics-based, mode-specific models for coseismic and precipitation-induced landslides capture the effects of multiple failure types and triggering scenarios.•A new model for analyzing slope stability against rotational failures allows for efficient, regional scale assessments.•Open-source mapping of built-up area is used to identify elements at risk.

11.
Sci Rep ; 8(1): 15596, 2018 10 22.
Article in English | MEDLINE | ID: mdl-30348979

ABSTRACT

We study quasi-spatially periodic signals (QSPSs) as a class of input signals of interest, which maintain their shapes quasi-periodically (with a phase change and a time shift) during propagation in an optical fibre. Instead of the computationally expensive nonlinear Fourier transform (NFT), the property of quasi-periodic shape invariant could be used as an alternative for decoding at the receiver. In this paper, properties of QSPSs and the signal design problem are studied, including the trade-off between various system parameters.

12.
Cureus ; 10(3): e2288, 2018 Mar 08.
Article in English | MEDLINE | ID: mdl-29770280

ABSTRACT

Background Obesity is an increasing public health concern associated with increased perioperative complications and expense in lumbar spine fusions. While open and mini-open fusions such as transforaminal lumbar interbody fusion (TLIF) and minimally invasive TLIF (MIS-TLIF) are more challenging in obese patients, new MIS procedures like oblique lateral lumbar interbody fusion (OLLIF) may improve perioperative outcomes in obese patients relative to TLIF and MIS-TLIF. Purpose The purpose of this study is to determine the effects of obesity on perioperative outcomes in OLLIF, MIS-TLIF, and TLIF. Study design This is a retrospective cohort study. Patient sample We included patients who underwent OLLIF, MIS-TLIF, or TLIF on three or fewer spinal levels at a single Minnesota hospital after conservative therapy had failed. Indications included in this study were degenerative disc disease, spondylolisthesis, spondylosis, herniation, stenosis, and scoliosis. Outcome measures We measured demographic information, body mass index (BMI), surgery time, blood loss, and hospital stay. Methods We performed summary statistics to compare perioperative outcomes in MIS-TLIF, OLLIF, and TLIF. We performed multivariate regression to determine the effects of BMI on perioperative outcomes controlling for demographics and number of levels on which surgeries were operated. Results OLLIF significantly reduces surgery time, blood loss, and hospital stay compared to MIS-TLIF, and TLIF for all levels. MIS-TLIF and TLIF do not differ significantly except for a slight reduction in hospital stay for two-level procedures. On multivariate analysis, a one-point increase in BMI increased surgery time by 0.56 ± 0.47 minutes (p = 0.24) in the OLLIF group, by 2.8 ± 1.43 minutes (p = 0.06) in the MIS-TLIF group, and by 1.7 ± 0.43 minutes (p < 0.001) in the TLIF group. BMI has positive effects on blood loss for TLIF (p < 0.001) but not for OLLIF (p = 0.68) or MIS-TLIF (p = 0.67). BMI does not have significant effects on length of hospital stay for any procedure. Conclusions Obesity is associated with increased surgery time and blood loss in TLIF and with increased surgery time in MIS-TLIF. Increased surgery time may be associated with increased perioperative complications and cost. In OLLIF, BMI does not affect perioperative outcomes. Therefore, OLLIF may reduce the disparity in outcomes and cost between obese and non-obese patients.

13.
Article in English | MEDLINE | ID: mdl-31379421

ABSTRACT

We have previously reported a realtime, open-source speech-processing platform (OSP) for hearing aids (HAs) research. In this contribution, we describe a wearable version of this platform to facilitate audiological studies in the lab and in the field. The system is based on smartphone chipsets to leverage power efficiency in terms of FLOPS/watt and economies of scale. We present the system architecture and discuss salient design elements in support of HA research. The ear-level assemblies support up to 4 microphones on each ear, with 96 kHz, 24 bit codecs. The wearable unit runs OSP Release 2018c on top of 64-bit Debian Linux for binaural HA with an overall latency of 5.6 ms. The wearable unit also hosts an embedded web server (EWS) to monitor and control the HA state in realtime. We describe three example web apps in support of typical audiological studies they enable. Finally, we describe a baseline speech enhancement module included with Release 2018c, and describe extensions to the algorithms as future work.

14.
S Afr Med J ; 106(2): 181-5, 2016 Jan 08.
Article in English | MEDLINE | ID: mdl-26821899

ABSTRACT

BACKGROUND: South Africa (SA)'s planned National Health Insurance reforms require the use of International Statistical Classification of Diseases (ICD) codes for hospitals to purchase services from the proposed National Health Authority. However, compliance with coding at public hospitals in the Western Cape Province has been challenging. A computer application was developed to aid clinicians in integrating ICD coding into the patient hospital discharge process. OBJECTIVE: To evaluate the quality of ICD codes captured using the application and predictors thereof in a single hospital department. METHODS: After 6 months, the quality of ICD codes was determined by comparing ICD code descriptors with medical concepts in a random sample of original patient records selected over a 6-week period. Patient and personnel characteristics influencing quality of coding, derived from a theoretical framework, were collected. RESULTS: Of 223 patient records, 45.3% (95% confidence interval (CI) 38.8 - 51.9) had complete ICD codes. Primary ICD code accuracy was 74.0% (95% CI 67.8 - 79.5). Patient characteristics such as female gender, younger age group and fewer comorbidities, as well as seniority of clinician rank, were significantly associated with ICD coding being complete on adjusted analysis. CONCLUSION: The results of this study describe ICD coding quality at a central hospital in SA supported by a computer application and the factors influencing this. More interventions are required to achieve reliable coding data, such as additional ICD coding validation tools, training and oversight of junior clinicians.

15.
Neurology ; 85(21): 1896-903, 2015 Nov 24.
Article in English | MEDLINE | ID: mdl-26598432

ABSTRACT

OBJECTIVE: To systematically review the evidence regarding rehabilitation treatments in multiple sclerosis (MS). METHODS: We systematically searched the literature (1970-2013) and classified articles using 2004 American Academy of Neurology criteria. RESULTS: This systematic review highlights the paucity of well-designed studies, which are needed to evaluate the available MS rehabilitative therapies. Weekly home/outpatient physical therapy (8 weeks) probably is effective for improving balance, disability, and gait (MS type unspecified, participants able to walk ≥5 meters) but probably is ineffective for improving upper extremity dexterity (1 Class I). Inpatient exercises (3 weeks) followed by home exercises (15 weeks) possibly are effective for improving disability (relapsing-remitting MS [RRMS], primary progressive MS [PPMS], secondary progressive MS [SPMS], Expanded Disability Status Scale [EDSS] 3.0-6.5) (1 Class II). Six weeks' worth of comprehensive multidisciplinary outpatient rehabilitation possibly is effective for improving disability/function (PPMS, SPMS, EDSS 4.0-8.0) (1 Class II). Motor and sensory balance training or motor balance training (3 weeks) possibly is effective for improving static and dynamic balance, and motor balance training (3 weeks) possibly is effective for improving static balance (RRMS, SPMS, PPMS) (1 Class II). Breathing-enhanced upper extremity exercises (6 weeks) possibly are effective for improving timed gait and forced expiratory volume in 1 second (RRMS, SPMS, PPMS, mean EDSS 4.5); this change is of unclear clinical significance. This technique possibly is ineffective for improving disability (1 Class II). Inspiratory muscle training (10 weeks) possibly improves maximal inspiratory pressure (RRMS, SPMS, PPMS, EDSS 2-6.5) (1 Class II).


Subject(s)
Academies and Institutes/standards , Multiple Sclerosis/diagnosis , Multiple Sclerosis/rehabilitation , Neurology/standards , Practice Guidelines as Topic/standards , Research Report/standards , Humans , Multiple Sclerosis/epidemiology , Neurology/methods , United States/epidemiology
16.
Traffic Inj Prev ; 16 Suppl 1: S31-5, 2015.
Article in English | MEDLINE | ID: mdl-26027973

ABSTRACT

OBJECTIVE: This article estimates the safety potential of a current commercially available connected vehicle technology in real-world crashes. METHOD: Data from the Centre for Automotive Safety Research's at-scene in-depth crash investigations in South Australia were used to simulate the circumstances of real-world crashes. A total of 89 crashes were selected for inclusion in the study. The crashes were selected as representative of the most prevalent crash types for injury or fatal crashes and had potential to be mitigated by connected vehicle technology. The trajectory, speeds, braking, and impact configuration of the selected in-depth cases were replicated in a software package and converted to a file format allowing "replay" of the scenario in real time as input to 2 Cohda Wireless MK2 onboard units. The Cohda Wireless onboard units are a mature connected vehicle technology that has been used in both the German simTD field trial and the U.S. Department of Transport's Safety Pilot project and have been tuned for low false alarm rates when used in the real world. The crash replay was achieved by replacing each of the onboard unit Global Positioning System (GPS) inputs with the simulated data of each of the involved vehicles. The time at which the Cohda Wireless threat detection software issued an elevated warning was used to calculate a new impact speed using 3 different reaction scenarios and 2 levels of braking. RESULTS: It was found that between 37 and 86% of the simulated crashes could be avoided, with highest percentage due a fully autonomous system braking at 0.7 g. The same system also reduced the impact speed relative to the actual crash in all cases. Even when a human reaction time of 1.2 s and moderate braking of 0.4 g was assumed, the impact speed was reduced in 78% of the crashes. Crash types that proved difficult for the threat detection engine were head-on crashes where the approach angle was low and right turn-opposite crashes. CONCLUSIONS: These results indicate that connected vehicle technology can be greatly beneficial in real-world crash scenarios and that this benefit would be maximized by having the vehicle intervene autonomously with heavy braking. The crash types that proved difficult for the connected vehicle technology could be better addressed if controller area network (CAN) information is available, such as steering wheel angle, so that driver intent can be inferred sooner. More accurate positioning in the real world (e.g., combining satellite positioning and accelerometer data) would allow the technology to be more effective for near-collinear head-on and rear-end crashes, because the low approach angles that are common in such crashes are currently ignored in order to minimize false alarms due to positioning uncertainty.


Subject(s)
Accidents, Traffic/prevention & control , Motor Vehicles , Protective Devices , Safety , Accidents, Traffic/statistics & numerical data , Computer Simulation , Humans , Pilot Projects , Software , South Australia , United States
18.
Mult Scler Relat Disord ; 3(2): 156-62, 2014 Mar.
Article in English | MEDLINE | ID: mdl-25878003

ABSTRACT

OBJECTIVES: To review the literature on vascular aspects of multiple sclerosis (MS) specifically pathological observations of the perivenular distribution of MS lesions and venous pathology in MS. METHODS: Comprehensive literature search from 2012 back to 1839. RESULTS: One hundred and thirty two papers from 1839 to 2012 were included in this study. Multiple authors observed central venules in MS lesions as a feature of MS with the first specific mention by Rindfleisch in 1863. Recent high field strength MRI has reintroduced the perivenular distribution of MS lesions to a new generation, and has suggested that there is disease specificity to this distribution. In addition Putnam and others in the 1930s hypothesized that venous disease was causative for MS. Treatments based on these observations have included anticoagulation, hyperbaric oxygen therapy, and recently endovascular venous procedures. The significance of these findings in terms of MS pathogenesis has been debated over the same period of time. CONCLUSIONS: While the controversy over venous disease in MS is new, the observation of perivenular MS plaques and venous theories about MS pathogenesis are as old as the history of MS research.

19.
Article in English | MEDLINE | ID: mdl-24032786

ABSTRACT

Stochastic Pooling Networks (SPNs) are a useful model for understanding and explaining how naturally occurring encoding of stochastic processes can occur in sensor systems ranging from macroscopic social networks to neuron populations and nanoscale electronics. Due to the interaction of nonlinearity, random noise, and redundancy, SPNs support various unexpected emergent features, such as suprathreshold stochastic resonance, but most existing mathematical results are restricted to the simplest case where all sensors in a network are identical. Nevertheless, numerical results on information transmission have shown that in the presence of independent noise, the optimal configuration of a SPN is such that there should be partial heterogeneity in sensor parameters, such that the optimal solution includes clusters of identical sensors, where each cluster has different parameter values. In this paper, we consider a SPN model of a binary hypothesis detection task and show mathematically that the optimal solution for a specific bound on detection performance is also given by clustered heterogeneity, such that measurements made by sensors with identical parameters either should all be excluded from the detection decision or all included. We also derive an algorithm for numerically finding the optimal solution and illustrate its utility with several examples, including a model of parallel sensory neurons with Poisson firing characteristics.

SELECTION OF CITATIONS
SEARCH DETAIL
...